California State Teachers Retirement System (CalSTRS)’s Immunome IMNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.44M Buy
111,444
+44,432
+66% +$989K ﹤0.01% 1413
2025
Q4
$1.44M Buy
67,012
+1,167
+2% +$20.5K ﹤0.01% 1602
2025
Q3
$771K Buy
65,845
+27,605
+72% +$275K ﹤0.01% 1896
2025
Q2
$356K Buy
38,240
+872
+2% +$7.15K ﹤0.01% 2173
2025
Q1
$251K Hold
37,368
﹤0.01% 2266
2024
Q4
$397K Sell
37,368
-385
-1% -$4.65K ﹤0.01% 2211
2024
Q3
$552K Sell
37,753
-1,108
-3% -$15.7K ﹤0.01% 2077
2024
Q2
$470K Buy
38,861
+6,180
+19% +$96.7K ﹤0.01% 2121
2024
Q1
$807K Buy
+32,681
New +$663K ﹤0.01% 1913
2021
Q2
Sell
-3,161
Closed -$107K 3170
2021
Q1
$107K Hold
3,161
﹤0.01% 3035
2020
Q4
$31K Buy
+3,161
New +$36.9K ﹤0.01% 3070

Other funds holding IMNM

California State Teachers Retirement System (CalSTRS)'s IMNM Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Immunome (IMNM) stake by 66% in Q1 2026, buying an estimated $989K and bringing the position to 111,444 shares worth $2.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1413.

California State Teachers Retirement System (CalSTRS) first reported a position in IMNM in Q4 2020 and has held it in 11 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 111,444 shares of Immunome worth $2.44M as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) bought 44,432 Immunome shares in Q1 2026, an estimated $989K.
  • Immunome made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #1413 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Immunome in Q4 2020 and has held it in 11 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.